vTv Therapeutics (VTVT) Receivables - Accured (2022 - 2025)
vTv Therapeutics (VTVT) reported Receivables - Accured of $11.9 million for Q4 2025, little changed on a YoY basis from $11.9 million in Q4 2024, and little changed sequentially from $11.9 million in Q4 2024.
vTv Therapeutics (VTVT) Receivables - Accured (2022 - 2025) Analysis & Trends
vTv Therapeutics (VTVT) has 4 years of Receivables - Accured data on file, last reported at $11.9 million in Q4 2025.
- For the quarter ending Q4 2025, Receivables - Accured changed 0.0% year-over-year to $11.9 million; the trailing twelve-month figure through Dec 2025 stood at $11.9 million (changed 0.0% YoY), and the FY2025 full-year result was $11.9 million, changed 0.0% from the prior year.
- Receivables - Accured was little changed at $11.9 million in Q4 2025, from $11.9 million in the prior quarter.
- In the past five years, Receivables - Accured ranged from a high of $11.9 million in Q3 2022 to a low of $11.9 million in Q3 2022.
- A 4-year average of $11.9 million and a median of $11.9 million in 2022 frame the typical range for Receivables - Accured.
- Peak annual rise in Receivables - Accured reached 0.0% in 2023, while the deepest fall reached 0.0% in 2023.
- Tracing VTVT's Receivables - Accured over 4 years: stood at $11.9 million in 2022, then changed by 0.0% to $11.9 million in 2023, then changed by 0.0% to $11.9 million in 2024, then changed by 0.0% to $11.9 million in 2025.
- Business Quant data shows VTVT's Receivables - Accured at $11.9 million in Q4 2025, $11.9 million in Q4 2024, and $11.9 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | vTv Therapeutics | 19.21 Mn | 19.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.90 Mn |
| Dec 31, 2025 | 11.90 Mn |
| Dec 31, 2024 | 11.90 Mn |
| Dec 31, 2024 | 11.90 Mn |
| Sep 30, 2024 | 11.90 Mn |
| Sep 30, 2024 | 11.90 Mn |
| Jun 30, 2024 | 11.90 Mn |
| Jun 30, 2024 | 11.90 Mn |
| Mar 31, 2024 | 11.90 Mn |
| Mar 31, 2024 | 11.90 Mn |
| Dec 31, 2023 | 11.90 Mn |
| Dec 31, 2023 | 11.90 Mn |
| Sep 30, 2023 | 11.90 Mn |
| Sep 30, 2023 | 11.90 Mn |
| Jun 30, 2023 | 11.90 Mn |
| Jun 30, 2023 | 11.90 Mn |
| Mar 31, 2023 | 11.90 Mn |
| Mar 31, 2023 | 11.90 Mn |
| Dec 31, 2022 | 11.90 Mn |
| Dec 31, 2022 | 11.90 Mn |